Sanofi, Bristol-Myers Fire Back In Plavix Feud

Law360, New York (August 14, 2006, 12:00 AM EDT) -- Hot on the heels of Apotex’ launch of an at-risk generic version of Plavix earlier this month, Sanofi-Aventis and Bristol-Myers Squibb are lashing out at the generic drug maker, filing a motion for a preliminary injunction on Monday in an attempt to block Apotex’ copycat version of the blood thinner.

The two pharmaceutical companies said Monday they had filed a motion for a preliminary injunction in the U.S. District Court for the Southern District of New York, ordering Apotex to halt its sales of a generic...
To view the full article, register now.